| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Veterans Administration Hospital and Departments of Biochemistry [R. C.] and Urology [R. C., C. C. I.], University of Tennessee Center for Health Sciences, Memphis, Tennessee 38104
Ethionine, a liver carcinogen, was administered p.o. (300 mg/kg) to rats 17 hr after partial hepatectomy. At 6 hr after administration of the ethionine, hepatic S-adenosylethionine levels were 30- to 40-fold greater than the hepatic level of S-adenosylethionine. A 10-fold ratio of S-adenosylethionine to S-adenosylmethionine still persisted at 24 hr after ethionine adminstration.
When given at 17 hr after partial hepatectomy, ethionine produced a 30% inhibition of DNA synthesis, measured by the incorporation of [methyl-3H]thymidine at 23 to 24 hr after partial hepatectomy (6 to 7 hr after ethionine administration). DNA synthesized during this interval was methyl deficient as judged by the reduced incorporation of radioactivity from L-[methyl-3H]methionine into 5-methylcytosine residues of DNA.
In an assay for DNA methylation in vitro using whole nuclei, the methyl-deficient DNA was methylated by S-adenosylmethionine 8 times more than was control DNA; the DNA methylation was competitively inhibited by S-adenosylethionine.
These data suggest that S-adenosylethionine, formed in vivo from ethionine, competitively inhibits the methylation of DNA in vivo by S-adenosylmethionine, resulting in the production of methyl-deficient DNA.
1 This investigation was supported by the United States Veterans Administration (4323-01) and by USPHS Research Grant CA-15189 from the National Cancer Institute.
Received 6/16/76. Accepted 10/13/76.
This article has been cited by other articles:
![]() |
L. A. Poirier The Effects of Diet, Genetics and Chemicals on Toxicity and Aberrant DNA Methylation: an Introduction J. Nutr., August 1, 2002; 132(8): 2336S - 2339. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Poirson-Bichat, R. A. B. Gonçalves, L. Miccoli, B. Dutrillaux, and M. F. Poupon Methionine Depletion Enhances the Antitumoral Efficacy of Cytotoxic Agents in Drug-resistant Human Tumor Xenografts Clin. Cancer Res., February 1, 2000; 6(2): 643 - 653. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |